Implanted port offers hope for SMA patients who Can't get standard spinal injections
Disease control
Recruiting now
This study is testing a small, implanted port and catheter system designed to deliver medication directly to the spinal fluid for people with spinal muscular atrophy (SMA) who cannot receive standard lumbar puncture injections. The device is intended for patients aged 3 and older…
Phase: NA • Sponsor: Alcyone Therapeutics, Inc • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC